Evidence map›Paper›PMID 35295097›Full record

ReviewFrontiers in toxicology2021

Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project.

Seiichi Ishida

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Organ-on-a-chip toxicology.Innovation (Cambridge (Mass.)) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Targeted Cancer Therapy-on-A-Chip.Advanced healthcare materials · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium.Toxicological sciences : an official journal of the Society of Toxicology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Seiichi IshidaDivision of Applied Life Science, Graduate School of Engineering, Sojo University, Kumamoto, Japan.
National Institute of Health Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microphysiological systems (MPS) have been actively developed as a new technology for

Indexed as

AMED-MPS projectcholestasisfibrosisliver-MPSliver zonationlong-term exposuremicrophyisiological systems

Identifiers

PMID35295097
PMCPMC8915811
OpenAlexW3158023867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.